John F Crowley - Net Worth and Insider Trading
John F Crowley Net Worth
The estimated net worth of John F Crowley is at least $7 Million dollars as of 2024-12-26. John F Crowley is the Executive Chairman of Amicus Therapeutics Inc and owns about 638,373 shares of Amicus Therapeutics Inc (FOLD) stock worth over $6 Million. John F Crowley is the Director of Entrada Therapeutics Inc and owns about 37,864 shares of Entrada Therapeutics Inc (TRDA) stock worth over $672,605. John F Crowley is also the Director of Intellia Therapeutics Inc and owns about 2,094 shares of Intellia Therapeutics Inc (NTLA) stock worth over $25,400. Details can be seen in John F Crowley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John F Crowley has not made any transactions after 2024-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John F Crowley
John F Crowley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John F Crowley owns 3 companies in total, including Intellia Therapeutics Inc (NTLA) , Amicus Therapeutics Inc (FOLD) , and Entrada Therapeutics Inc (TRDA) .
Click here to see the complete history of John F Crowley’s form 4 insider trades.
Insider Ownership Summary of John F Crowley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | 2021-10-11 | director |
| FOLD | Amicus Therapeutics Inc | 2024-03-01 | director & Executive Chairman |
| TRDA | Entrada Therapeutics Inc | 2022-01-12 | director |
John F Crowley Latest Holdings Summary
John F Crowley currently owns a total of 3 stocks. Among these stocks, John F Crowley owns 638,373 shares of Amicus Therapeutics Inc (FOLD) as of March 1, 2024, with a value of $6 Million and a weighting of 89.96%. John F Crowley owns 37,864 shares of Entrada Therapeutics Inc (TRDA) as of January 12, 2022, with a value of $672,605 and a weighting of 9.67%. John F Crowley also owns 2,094 shares of Intellia Therapeutics Inc (NTLA) as of October 11, 2021, with a value of $25,400 and a weighting of 0.37%.
Latest Holdings of John F Crowley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FOLD | Amicus Therapeutics Inc | 2024-03-01 | 638,373 | 9.80 | 6,256,055 |
| TRDA | Entrada Therapeutics Inc | 2022-01-12 | 37,864 | 17.76 | 672,605 |
| NTLA | Intellia Therapeutics Inc | 2021-10-11 | 2,094 | 12.13 | 25,400 |
Holding Weightings of John F Crowley
John F Crowley Form 4 Trading Tracker
According to the SEC Form 4 filings, John F Crowley has made a total of 90 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years, including 0 buys and 90 sells. The most-recent trade in Amicus Therapeutics Inc is the sale of 29,181 shares on March 1, 2024, which brought John F Crowley around $389,566.
According to the SEC Form 4 filings, John F Crowley has made a total of 1 transactions in Entrada Therapeutics Inc (TRDA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Entrada Therapeutics Inc is the acquisition of 5,000 shares on January 12, 2022, which cost John F Crowley around $48,600.
According to the SEC Form 4 filings, John F Crowley has made a total of 2 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Intellia Therapeutics Inc is the sale of 2,500 shares on October 11, 2021, which brought John F Crowley around $298,875.
Insider Trading History of John F Crowley
- 1
John F Crowley Trading Performance
GuruFocus tracks the stock performance after each of John F Crowley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John F Crowley is -19.7%. GuruFocus also compares John F Crowley's trading performance to market benchmark return within the same time period. The performance of stocks bought by John F Crowley within 3 months outperforms 0 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John F Crowley's insider trading performs compared to the benchmark.
Performance of John F Crowley
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.38 | | | | | |
| Relative Return to S&P 500(%) | 3.72 | | | | | |
John F Crowley Ownership Network
John F Crowley Owned Company Details
What does Intellia Therapeutics Inc do?
Who are the key executives at Intellia Therapeutics Inc?
John F Crowley is the director of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Technical Officer Eliana Clark , EVP & Chief Scientific Officer Laura Sepp-lorenzino , and EVP & Chief Business Officer Derek Hicks .
Intellia Therapeutics Inc (NTLA) Insider Trades Summary
Over the past 18 months, John F Crowley made no insider transaction in Intellia Therapeutics Inc (NTLA). Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 5,373 shares made by Eliana Clark , a net sale of 2,397 shares made by Muna Bhanji , and a net sale of 7,807 shares made by Laura Sepp-lorenzino .
In summary, during the past 3 months, insiders sold 2,012 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 2,012 shares. During the past 18 months, 57,207 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 57,207 shares.
Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intellia Therapeutics Inc Insider Transactions
John F Crowley Mailing Address
Above is the net worth, insider trading, and ownership report for John F Crowley. You might contact John F Crowley via mailing address: C/o Amicus Therapeutics, Inc., 1 Cedar Brook Drive, Cranbury Nj 08512.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
